Skip to content
Aperlena

Spain - Pharmaceutical products - Framework supply agreement (CONTR 2026 0000292688)

Original España - Productos farmacéuticos - Contrato Acuerdo Marco de Suministro (CONTR 2026 0000292688)

Open Contract notice

Key facts

Closes in
2 days
Where
Spain Andalucía
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
Spanish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 10 hours ago
Notice number
662568-2026
Watch this tender

If the deadline moves or the notice is corrected, we email you. Log in

  1. Published
  2. Today
  3. Deadline open for 6 days
  4. Awarded pending

Summary

Machine-generated summary

The Andalusian Health Service (Servicio Andaluz de Salud) is awarding a framework agreement with several companies, setting conditions for successive-tranche supply at unit prices under Article 16.3 a) of the LCSP, for selected medicines. The medicines covered are abacavir, abemaciclib, aflibercept, alpha-1-antitrypsin, amoxicillin, apremilast, aripiprazole, avelumab, BCG (dried live culture), carfilzomib, ceftazidime, ceftriaxone, colistin, daratumumab, dasatinib and denosumab. The supplies are destined for healthcare centres of the Andalusian Health Service. The total budget amounts to EUR 256,886,101.58 including VAT. Lot 1 is designated AM SUM.

Description

ACUERDO MARCO CON VARIAS EMPRESAS, POR EL QUE SE FIJAN LAS CONDICIONES PARA EL SUMINISTRO DE TRACTO SUCESIVO Y PRECIO UNITARIO AL AMPARO DEL ART. 16.3. a) DE LA LCSP, DE MEDICAMENTOS SELECCIONADOS (ABACAVIR, ABEMACICLIB, AFLIBERCEPT, ALFA-1-ANTITRIPSINA, AMOXICILINA, APREMILAST, ARIPIPRAZOL, AVELUMAB, BCG (CULTIVO VIVO DESECADO), CARFILZOMIB, CEFTAZIDIMA, CEFTRIAXONA, COLISTINA, DARATUMUMAB, DASATINIB Y, DENOSUMAB), DESTINADOS A LOS CENTROS SANITARIOS DEL SERVICIO ANDALUZ DE SALUD. Presupuesto total: 256.886.101,58 € (IVA incluido). Lote 1 AM SUM

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in Spanish.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 10 hours ago

More from this buyer

Full buyer profile

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Spain

Company Wins Total awarded Last win
NOVARTIS FARMACEUTICA, S.A. 112 €152.1M Sep 2026
GILEAD SCIENCES, S.L. 98 €56.8M Sep 2026
MEDTRONIC IBÉRICA, S.A. 84 €259.6M Sep 2026
PALEX MEDICAL, S.A. 81 €250.6M Sep 2026
GLAXOSMITHKLINE, S.A. 78 €273.4M Sep 2026

Based on 7226 awards with a linked company profile over the last 2 years.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,311,844
9,630 open across Europe right now
Buyer track record on Aperlena
90 notices tracked · 57 awarded
€304,257,054 in awarded contracts

Never miss a tender like this

835 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

2 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language